sepsis Archive
-
October 25, 2022
Vascular dysfunction during sepsis
Regulation of the enzyme Sirtuin 1 in blood vessel endothelial cells may drive altered metabolism and vascular dysfunction during sepsis, Vanderbilt researchers have discovered. -
January 13, 2020
Zinc uptake by a deadly pathogen
The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses. -
October 3, 2019
New test assists physicians with quicker treatment decisions for sepsis
Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing. -
May 9, 2018
Putting the brakes on sepsis
An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection. -
February 15, 2018
Sepsis trial ranked No. 1 on critical care website
A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line. -
June 22, 2017
VU scientists report a way to calm the sepsis “storm”
Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis. -
February 8, 2017
Pathology of septic shock
The signaling molecule IL-15 promotes septic shock, a life-threatening condition involving organ injury caused by infection.